Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
about
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysisDrug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial HypertensionDiabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studiesAlcohol drinking and risk of Parkinson's disease: a case-control study in JapanIntegrated molecular landscape of Parkinson's diseaseSerum cholesterol and the progression of Parkinson's disease: results from DATATOP.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Diabetes and risk of Parkinson's disease.Diabetes and the risk of developing Parkinson's disease in Denmark.The risk of Parkinson disease associated with urate in a community-based cohort of older adults.Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective studyParkinson's disease between internal medicine and neurologyMetabolic markers or conditions preceding Parkinson's disease: a case-control study.Diabetes is associated with postural instability and gait difficulty in Parkinson diseaseRisk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's DiseaseDietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Arterial hypertension, a tricky side of Parkinson's disease: physiopathology and therapeutic features.The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.Movement disorders and cerebrovascular diseases: from pathophysiology to treatment.Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy.Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's RiskMechanisms of multiple neurotransmitters in the effects of Lycopene on brain injury induced by Hyperlipidemia.The serum lipid profile of Parkinson's disease patients: a study from China.Hypertension and Diagnosis of Parkinson's Disease: A Meta-Analysis of Cohort Studies.27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons.The Therapeutic Potential of Metformin in Neurodegenerative DiseasesImpact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease
P2860
Q26849796-EBFF1203-A3C1-41CE-91A5-60E53DF86B24Q28085554-3848F1AF-8846-4239-817F-E80525680629Q28538916-77D5B8B8-F2E1-426B-A5CC-9FB2615D882DQ33739908-BD4066C7-F8F4-4EB4-920E-F92257C2D9C2Q33767544-6E23F9E7-44F3-44D1-BEAF-0D202ACFA3BDQ33996828-2DFF0FD1-E737-44E5-9AD7-2C716E89CC11Q34243731-AA931867-64B2-46ED-8841-6CE723CBC498Q34718429-F8850E30-0989-42AC-BDC6-35EAE5998363Q35043736-A572DA23-D3C9-479C-A96F-794A0156CDCEQ35071745-CD4F8D6E-BBB3-4EA6-AB66-361734B224D0Q35328089-8283DAA1-8B2B-4054-8B2F-B6CD9700A3CAQ36464243-61FA780F-3413-4C39-A8C4-8CBC21F986A1Q36516892-7B1BFA8F-9595-4230-B2A2-726513F6689FQ36715663-15C1D1C1-64E3-4D2C-B320-9C9E89887E68Q36891855-9703ECC9-2043-42B6-8404-B7D851EB961BQ36983489-5745220B-2572-476D-9852-89FD94C7067BQ37058206-F7190E82-D05D-4DFE-B4EA-F5360F3F845EQ37962621-1B37B58C-331B-4206-8C82-D3A6F911512DQ38063423-FBFDCECB-CC7C-4569-9BDD-C162502E7A3AQ38539827-C8A0467F-4C9D-4164-8F5B-2AFC67A0E04FQ38859501-F385AFC9-0AE6-4B86-A1F7-CB55361ACCB4Q39039326-CB7C38D7-051F-43ED-9DE9-C96747F4C50CQ40449997-6F6540D4-42CB-40A8-963E-6143136D8E09Q42145966-1C550AB9-4822-4284-9349-55290C250D72Q49311550-7E36CB8E-6CAD-4B65-A52A-27DB09C52426Q51313784-1EE37091-4895-4652-9BFE-2CACD383E86AQ52608617-C7FE3A84-498D-40DC-9FE3-4197CCD06575Q55236585-E431D357-DBD9-45E3-AE9B-C0468FFA864AQ57175337-D0F9BE48-364B-4AB4-B5B7-910B70C889DAQ59153352-045B35BE-7744-4464-87A2-46FC4E0717C1
P2860
Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Case-control study of risk of ...... olemia, and diabetes in Japan.
@en
Case-control study of risk of ...... olemia, and diabetes in Japan.
@nl
type
label
Case-control study of risk of ...... olemia, and diabetes in Japan.
@en
Case-control study of risk of ...... olemia, and diabetes in Japan.
@nl
prefLabel
Case-control study of risk of ...... olemia, and diabetes in Japan.
@en
Case-control study of risk of ...... olemia, and diabetes in Japan.
@nl
P2093
P1476
Case-control study of risk of ...... olemia, and diabetes in Japan.
@en
P2093
Chikako Kiyohara
Fukuoka Kinki Parkinson's Disease Study Group
Hidenao Fukuyama
Masaki Nagai
Nobutaka Sakae
Nobutoshi Kawamura
Satoshi Sasaki
Takami Miki
Tatsuo Yamada
Tomoko Oeda
P356
10.1016/J.JNS.2010.03.002
P577
2010-03-29T00:00:00Z